USE OF COMPOSITIONS DEPLETED OF DENDRITIC CELLS FOR IMPROVING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

• 1. 用于改善同种异型的造血细胞移植的方法和组合物 [P] . 中国专利： CN1333688A . 2002-01-30
• 2. 用于同种异体γ/δ-T细胞的扩增和使用的方法和组合物 [P] . 中国专利： CN112930187A . 2021-06-08
• 3. USE OF DENDRITIC CELL-DEPLETED COMPOSITIONS TO IMPROVE THE TRANSPLANTATION OF ALLOGENIC HEMATOPOIETIC CELLS [P] . 德国专利： DE69916302T2 . 2005-05-04

  机译： 使用树突状细胞缺失的组合物改善同种异体造血细胞的移植

• 4. USE OF DENDRITIC CELL-DEPLETED COMPOSITIONS TO IMPROVE THE TRANSPLANTATION OF ALLOGENIC HEMATOPOIETIC CELLS [P] . AT263833T . 2004-04-15

  机译： 使用树突状细胞缺失的组合物改善同种异体造血细胞的移植

• 5. Method and compositions for improving allogeneic hematopoietic cell transplantation [P] . AU779039B2 . 2005-01-06

  机译： 改善同种异体造血细胞移植的方法和组合物

• 1. Rapid identification of the origin of hematopoietic cells after allogeneic hematopoietic stem cell transplantation for leukemia with DNA-fingerprinting [J] . 钱新华, 邢献志, 朱为国, 中国人民解放军军医大学学报：英文版 . 1997,第001期
• 2. Donor-Derived CD19-Targeted T Cell Infusion Eliminates B Cell Acute Lymphoblastic Leukemia Minimal Residual Disease with No Response to Donor Lymphocytes after Allogeneic Hematopoietic Stem Cell Transplantation [J] . Yifei Cheng, Kaiyan Liu, Shasha Wang, 工程（英文） . 2019,第001期
• 3. Donor-Derived CD19-Targeted T Cell Infusion Eliminates B Cell Acute Lymphoblastic Leukemia Minimal Residual Disease with No Response to Donor Lymphocytes after Allogeneic Hematopoietic Stem Cell Transplantation [J] . Yifei Cheng, Yuhong Chen, Chenhua Yan, 工程（英文） . 2019,第001期
• 4. THE EFFECT OF INHIBITORY KILLER-CELL IG-LIKE RECEPTOR (IKIR) MATCHING IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT) [C] . David Senitzer, Joel Y. Sun, Arisa Oki, Clinical Histocompatibility Workshop. . 2009
• 5. Donor selection for patients undergoing allogeneic hematopoietic stem cell transplantation: Assessment of the priorities of Canadian hematopoietic stem cell transplant physicians. [D] . Tay, Jason. 2009
• 6. Cytokine Complex–expanded Natural Killer Cells Improve Allogeneic Lung Transplant Function via Depletion of Donor Dendritic Cells [O] . Wolfgang Jungraithmayr, Laura Codarri, Gregory Bouchaud, -1
• 7. In vivo T-cell depletion with pretransplant low-dose antithymocyte globulin is associated with reduced transplant-related mortality and improved clinical outcome in patients receiving allogeneic hematopoietic stem cell transplantation from unrelated and partially matched related donors [O] . BUSCA A, LOCATELLI F, FLONTA SE, 2011

• 1. WJSC 6^(th) Anniversary Special Issues(1):Hematopoietic stem cell transplantation Allogeneic hematopoietic cell transplant for acute myeloid leukemia:Current state in 2013 and future directions [J] . Abraham S Kanate ,Marcelo C Pasquini ,Parameswaran N Hari . 世界干细胞杂志：英文版（电子版） . 2014,第2期
• 2. Umbilical Cord Blood-derived Mesenchymal Stem Cells Ameliorate Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation through Multiple Immunoregulations [J] . Qiu-ling WU ,Xiao-yun LIU ,Di-min NIE . 华中科技大学学报（医学）（英德文版） . 2015,第004期
• 3. 同种异体反应性NK细胞在造血干细胞移植中作用的研究进展 [C] . 徐喜慧 ,欧阳建 . 2006年江苏省博士生研究生学术论坛—中医药创新与发展 . 2006
• 4. 抗Tim-3单抗联合化疗药物对同种异体造血干细胞移植后淋巴瘤复发和黑色素瘤的治疗研究 [A] . 刘扬 . 2017